EHC - Company ID 0000785161
The table below shows Encompass Health Corp's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | - | - | - | $227.90M | $218.90M | $158.50M |
| Capital expenditure | - | - | - | $96.60M | $112.90M | $98.80M |
| Investing cash flow | -$150.10M | -$158.50M | -$129.70M | -$104.00M | -$123.10M | -$95.60M |
| Dividends paid | $20.30M | $18.00M | $15.90M | $15.60M |
Encompass Health Corp reported operating cash flow of $705.80M for fiscal year 2022. That is down 1.4% from $715.80M in fiscal 2021. Over the 10 fiscal years shown, operating cash flow grew from $470.30M (FY 2013) to $705.80M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $28.50M |
| $29.10M |
| Stock buybacks | $71.60M | $32.10M | $0.00 | - | - | - |
| Financing cash flow | -$102.50M | -$130.40M | -$40.60M | -$58.00M | -$60.90M | -$77.50M |